CFM
SEM

Catalyst Funds Management’s Select Medical SEM Stock Holding History

Catalyst Funds Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,454
Closed -$83.7K – 1109
2024
Q3 		$83.7K Buy
+4,454
New +$85.3K 0.02% 558
2024
Q2 		– Sell
-557
Closed -$9.04K – 1552
2024
Q1 		$9.04K Buy
+557
New +$8.15K ﹤0.01% 899

Other funds holding SEM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Catalyst Funds Management's SEM Position: Q4 2024 in Review

Catalyst Funds Management sold out of Select Medical (SEM) in Q4 2024, closing a stake of 4,454 shares — an estimated $83.7K sold.

Catalyst Funds Management first reported a position in SEM in Q1 2024 and held it in 2 quarters. The position peaked at $83.7K in Q3 2024. 271 funds tracked by Wall St. Rank hold SEM as of Q4 2024.

  • Catalyst Funds Management reported no remaining Select Medical position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 4,454 Select Medical shares in Q4 2024, an estimated $83.7K.
  • Catalyst Funds Management first reported a position in Select Medical in Q1 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Select Medical position peaked at $83.7K in Q3 2024.
  • 271 funds tracked by Wall St. Rank held Select Medical as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.